Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology

Joint Authors

Xie, Xuejiao
Ma, Xingyu
Zeng, Siyu
Tang, Wansi
Xiao, Liucheng
Zhu, Chenggong
Yu, Rong

Source

Evidence-Based Complementary and Alternative Medicine

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-03-19

Country of Publication

Egypt

No. of Pages

11

Main Subjects

Medicine

Abstract EN

Atherosclerosis is a common metabolic disease characterized by lipid metabolic disorder.

The processes of atherosclerosis include endothelial dysfunction, new endothelial layer formation, lipid sediment, foam cell formation, plaque formation, and plaque burst.

Owing to the adverse effects of first-line medications, it is urgent to discover new medications to deal with atherosclerosis.

Berberine is one of the most promising natural products derived from traditional Chinese medicine.

However, the panoramic mechanism of berberine against atherosclerosis has not been discovered clearly.

In this study, we used network pharmacology to investigate the interaction between berberine and atherosclerosis.

We identified potential targets related to berberine and atherosclerosis from several databases.

A total of 31 and 331 putative targets for berberine and atherosclerosis were identified, respectively.

Then, we constructed berberine and atherosclerosis targets with PPI data.

Berberine targets network with PPI data had 3204 nodes and 79437 edges.

Atherosclerosis targets network with PPI data had 5451 nodes and 130891 edges.

Furthermore, we merged the two PPI networks and obtained the core PPI network from the merged PPI network.

The core PPI network had 132 nodes and 3339 edges.

At last, we performed functional enrichment analyses including GO and KEGG pathway analysis in David database.

GO analysis indicated that the biological processes were correlated with G1/S transition of mitotic cells cycle.

KEGG pathway analysis found that the pathways directly associated with berberine against atherosclerosis were cell cycle, ubiquitin mediated proteolysis, MAPK signaling pathway, and PI3K-Akt signaling pathway.

After combining the results in context with the available treatments for atherosclerosis, we considered that berberine inhibited inflammation and cell proliferation in the treatment of atherosclerosis.

Our study provided a valid theoretical foundation for future research.

American Psychological Association (APA)

Xie, Xuejiao& Ma, Xingyu& Zeng, Siyu& Tang, Wansi& Xiao, Liucheng& Zhu, Chenggong…[et al.]. 2020. Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine،Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1155767

Modern Language Association (MLA)

Xie, Xuejiao…[et al.]. Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine No. 2020 (2020), pp.1-11.
https://search.emarefa.net/detail/BIM-1155767

American Medical Association (AMA)

Xie, Xuejiao& Ma, Xingyu& Zeng, Siyu& Tang, Wansi& Xiao, Liucheng& Zhu, Chenggong…[et al.]. Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine. 2020. Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1155767

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1155767